We invite you to read an interview with Maciej Gołaszewski, a board member of BioCloner Health.
Using our proprietary 3D bioprinter, the BioCloner Desktop Pro, we are conducting research related to implants. We provide the technology and carry out our own R&D activities. We are currently in the early stages of producing a meniscus implant that will integrate with native tissue and be tailored to each individual patient, says Maciej Gołaszewski.
Link to the interview:
https://www.wprost.pl/nauka-dla-rozwoju-medycyny/11788770/technologia-biodrukowania-3d-ma-wiele-zalet-ogranicza-testy-na-zwierzetach-dostarcza-spersonalizowane-leki-i-implanty.html